Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Lotiglipron

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

Pfizer · Phase 1 · Terminated · Enrollment 16

NCT05788328

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Period 1n/rn/rn/rn/r
Period 2n/rn/rn/rn/r
Period 3n/rn/rn/rn/r
Period 4n/rn/rn/rn/r
Period 5n/rn/rn/rn/r
Period 6n/rn/rn/rn/r
Period 7n/rn/rn/rn/r
Period 8n/rn/rn/rn/r

Not shown

  • Period 1: endpoint not reported
  • Period 2: endpoint not reported
  • Period 3: endpoint not reported
  • Period 4: endpoint not reported
  • Period 5: endpoint not reported
  • Period 6: endpoint not reported
  • Period 7: endpoint not reported
  • Period 8: endpoint not reported